[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"thrombosis-embolism\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:thrombosis-embolism":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100546348","cancer-related-venous-thromboembolic-disease---cohort-study-100546348",false,"NCT06393764","Cancer-related Venous Thromboembolic Disease - Cohort Study","Establishment of a Patient-based Cohort : Cancer-related Venous Thromboembolic Disease.","CAPE","Inclusion Criteria:\n\n* Patients aged 18 years and more.\n* Patients with active cancer or requiring cancer treatment at the time of their VTE episode\n* Patients with documented VTE less than 2 years old\n* Patients affiliated to the social security system\n* Patient who has signed a written informed consent\n\nExclusion Criteria:\n\n* Patient under 18\n* Refusal to participate\n* Incapacity to consent to the study\n* Patient under guardianship\n* Incapacity to communicate (comprehension disorder)\n* Life expectancy of less than 6 months","ALL","18 Years","80 Years",{"count":21,"type":22},150,"ESTIMATED","OBSERVATIONAL","Venous thromboembolic disease (VTE) is a common (1\u002F1000), potentially serious disease (10% mortality when the clinical presentation is that of pulmonary embolism (PE)). In cancer patients, the risk of developing VTE is high and constitutes a negative prognostic factor for cancer; the risk of bleeding is also increased. The study of VTE in the context of cancer is a major challenge, given the frequency of the association, the heterogeneity of the situations, the risk factors involved and the therapeutic issues in both curative and primary prevention; in this field, many uncertainties remain, justifying a study focused on the association of VTE and cancer.",[26,27,28],"Thrombosis Embolism","Thromboses, Venous","Cancer","RECRUITING","2026-06-12",{"date":32,"type":33},"2026-06-15","ACTUAL",{"date":35,"type":33},"2025-10-30",{"date":37,"type":22},"2035-10",{"name":39,"class":40},"University Hospital, Brest","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":50,"targetDuration":52,"studyType":23,"phases":4,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":41},"100353396","ongoing-registry-of-treatment-of-venous-thromboembolism-100353396","NCT03881345","Ongoing Registry of Treatment of Venous Thromboembolism","Russian Registry of Treatment of Venous Thromboembolism","RRT VTE","Inclusion Criteria:\n\n* case of venous thrombosis of a limb or pulmonary embolus\n\nExclusion Criteria:\n\n* no exclusion criteria",{"count":51,"type":22},5000,"12 Months","Ongoing registration of patients with venous thromboembolism treated by means of antithrombotic therapy, thrombolisys, open surgery, endovenous desobstruction and stenting.",[55,27,26,56,57],"Deep Vein Thrombosis","Postthrombotic Syndrome","Pulmonary Embolism","2025-05-05",{"date":60,"type":33},"2025-05-08",{"date":62,"type":33},"2019-04-01",{"date":64,"type":22},"2036-03-01",{"name":66,"class":40},"Medalp Private Surgery Clinic"]